DOSSIER · 13F-HR · Q2 2026
REGENERON PHARMACEUTICALS, INC.
$177M in tracked AUM across 3 positions as of Q2 2026.
RP
CIK 0000872589 · last filed Jun 30, 2026
AI Analysis · Q2 2026
Portfolio Overview
The SEC 13F filing for Regeneron Pharmaceuticals, Inc. (CIK: 0000872589) reveals a highly concentrated investment portfolio managed with a distinct strategic focus. As of the reporting date September 30, 2025, the total portfolio value stands at approximately $699.66 million. This represents a significant decrease of 52.9% from the previous quarter's value of $1.49 billion. The portfolio consists of only three holdings, indicating an aggressive concentration strategy rath...
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology
Quarter at a glance — Q2 2026
Position-change comparison pending.
No quarter-over-quarter changes available.
Top 10 holdings
By portfolio weight as of Q2 2026.